Discovered in 2006, and awarded the Nobel Prize in 2012, induced pluripotent stem cells (iPSCs) have been waiting in the wings of the theater of drug development. The global iPSC market will see steady growth over the next few years, growing 9.2% annually to reach $3.8 billion by 2024.
Topics: Life Sciences, Biotechnology
Remdesivir—the experimental COVID19 treatment developed by Gilead Sciences—is having its moment.
Topics: Life Sciences
Robots have historically been designed to serve, be it in industrial, military, medical or other settings.
Emerging now is a new category of robot: Social.
